AB-Biotics S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,899.30
1,681.50
640.70
2,699.50
2,454.70
2,773.10
Total Accounts Receivable
1,043.80
1,938.80
2,095.90
1,336.50
2,182.00
3,817.20
Inventories
259.60
323.80
318.50
333.40
275.50
608.90
Total Current Assets
4,202.60
3,944.10
3,055.00
4,369.40
4,912.20
7,199.30
Net Property, Plant & Equipment
433.30
434.60
395.40
340.80
284.30
203.70
Total Investments and Advances
1,589.40
520.10
242.80
480.50
664.40
664.40
Long-Term Note Receivable
2,067.90
1,660.80
101.30
44.90
18.60
4.10
Intangible Assets
4,072.20
4,233.00
6,718.50
7,223.30
6,290.50
6,430.40
Total Assets
14,961.60
14,119.40
13,806.90
12,546.20
12,170.00
15,154.30
ST Debt & Current Portion LT Debt
357.10
817.70
1,002.60
842.90
943.20
Accounts Payable
124.70
101.30
223.20
446.30
685.30
Income Tax Payable
110.40
166.70
112.40
145.10
141.50
Other Current Liabilities
733.60
657.00
1,652.40
1,703.20
2,013.30
Total Current Liabilities
1,325.80
1,742.70
2,990.60
3,137.40
3,783.30
Long-Term Debt
1,473.90
3,584.20
3,591.10
3,714.30
3,481.20
Deferred Taxes
2,498.50
3,209.60
3,193.80
40.10
165.50
Other Liabilities
2,116.50
-
-
-
-
Total Liabilities
5,013.90
5,444.00
6,682.00
6,979.10
7,430.00
Common Equity (Total)
9,654.70
8,323.80
6,824.40
5,184.90
4,243.60
Total Shareholders' Equity
9,654.70
8,323.80
6,824.40
5,184.90
4,243.60
Total Equity
9,654.70
8,323.80
6,824.40
5,184.90
4,243.60
Liabilities & Shareholders' Equity
14,961.60
14,119.40
13,806.90
12,546.20
12,170.00
Non-Equity Reserves
293.10
351.60
300.60
382.10
496.50

About AB-Biotics

View Profile
Address
Esade Creapolis
Barcelona Catalonia 08172
Spain
Employees -
Website http://www.ab-biotics.com
Updated 07/08/2019
AB-Biotics SA engages in the research, development, innovation, and production of biotechnological solutions. It operates through the Probiotics and Genetic Tests business areas. The Probiotics business area offers probiotics for cardiometabolic, oral care, pediatrics, gastrointestinal health, gynaecology and urology, and dermatology and immunology.